Valproate, lamotrigine, and insulin‐mediated risks in women with epilepsy
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
We recently reported the frequent occurrence of polycystic ovaries and hyperandrogenism associated with weight gain and hyperinsulinemia in women taking valproate for epilepsy. The purpose of this study was to evaluate the risks related to valproate‐induced hyperinsulinemia and their reversibility after discontinuing the medication. Sixteen women with valproate‐related polycystic ovaries or hyperandrogenism participated in the study. Vaginal ultrasonography was performed, and endocrine and lipid parameters were measured. Thereafter, lamotrigine was substituted for valproate and the patients were observed for 12 months. Twenty‐four healthy age‐matched women served as control subjects. Twelve women completed the 12‐month follow‐up. While still on valproate they had centripetal obesity with associated hyper insulinemia and unfavorable serum lipid profiles. The body‐mass index and fasting serum insulin and testosterone concentrations decreased during the first year after replacing valproate with lamotrigine whereas the HDL‐cholesterol/total cholesterol ratios increased from 0.17 ± 0.06 to 0.26 ± 0.05. The total number of polycystic ovaries in these women decreased from 20 during valproate medication to 11 one year after replacing valproate with lamotrigine. Valproate induces a metabolic syndrome with centripetal obesity, hyperinsulinemia lipid abnormalities, and polycystic ovaries/hyperandrogenism in women with epilepsy. These valproate‐related risks can be reduced by substituting lamotrigine for valproate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Epileptic Syndromes in Infancy, Childhood and Adolescence
Rogers, J., Bureau, M., Dravet, C., Dreifuss, F. E., Perret, A., Wolf, P., & Armstrong, D. L. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199307000-00012 · Cited by 1,470
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams, J., Polson, D. W., & Franks, S. (1986) · BMJ · doi:10.1136/bmj.293.6543.355 · Cited by 981
Han, T. S., van Leer, E. M., Seidell, J. C., & Lean, M. E. J. (1995) · BMJ · doi:10.1136/bmj.311.7017.1401 · Cited by 976
Insulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 801
Polycystic Ovaries and Hyperandrogenism in Women Taking Valproate for Epilepsy
Isojarvi, J., Laatikainen, T. J., Pakarinen, A. J., Juntunen, K., & Myllyla, V. V. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311043291904 · Cited by 688
Self-citationMattson, R. H., Cramer, J. A., & Collins, J. F. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209103271104 · Cited by 683
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
Brodie, M. J., UK Lamotrigine/Carbamazepine Monotherapy Trial Group, Richens, A., & Yuen, A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90581-2 · Cited by 615
Enzyme immunoassay for intact human insulin in serum or plasma
Andersen, L., Dinesen, B., Jørgensen, P. N., Poulsen, F., & Røder, M. E. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.4.578 · Cited by 520
Reproductive Endocrine Disorders in Men With Partial Seizures of Temporal Lobe Origin
Herzog, A. G., Seibel, M. M., Schomer, D. L., Vaitukaitis, J. L., & Geschwind, N. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520040035015 · Cited by 466
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
Conway, G. S., Agrawal, R., Betteridge, D. J., & Jacobs, H. S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02295.x · Cited by 427
Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement.
Finley, P. R., Schifman, R. B., Williams, R. J., & Lichti, D. A. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.6.931 · Cited by 418
Obesity and endocrine disorders in women taking valproate for epilepsy
Isojärvi, J. I. T., Laatikainen, T. J., Knip, M., Pakarinen, A. J., Juntunen, K. T. S., & Myllyla, V. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390506 · Cited by 378
Self-citationReproductive Endocrine Disorders in Women With Partial Seizures of Temporal Lobe Origin
Herzog, A. G., Seibel, M. M., Schomer, D. L., Vaitukaitis, J. L., & Geschwind, N. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520040029014 · Cited by 348
Clinical signs of androgen excess as risk factors for coronary artery disease
Wild, R. A., Grubb, B., Hartz, A., Van Nort, J. J., Bachman, W., & Bartholomew, M. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53699-1 · Cited by 183
Effects of sodium valproate in 100 children with special reference to weight.
Egger, J., & Brett, E. M. (1981) · BMJ · doi:10.1136/bmj.283.6291.577 · Cited by 170
Reproductive Endocrine Disorders in Women with Primary Generalized Epilepsy
Bilo, L., Meo, R., Nappi, C., Annunziato, L., Striano, S., Colao, A. M., Merola, B., & Buscaino, G. A. (1988) · Epilepsia · doi:10.1111/j.1528-1157.1988.tb03770.x · Cited by 154
Clinical implications of hyperinsulinaemia in women
Conway, G. S., & Jacobs, H. S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02419.x · Cited by 73
Ponchaut, S., & Veitch, K. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90404-k · Cited by 59
Cited by
Epidemiology, diagnosis, and management of polycystic ovary syndrome
Sirmans, S., & Pate, K. (2013) · Clinical Epidemiology · doi:10.2147/clep.s37559 · Cited by 1,302
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
The Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 818
Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study
Henderson, D. C., Cagliero, E., Gray, C., Nasrallah, R. A., Hayden, D. L., Schoenfeld, D. A., & Goff, D. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.975 · Cited by 701
Perucca, E. (2002) · CNS Drugs · doi:10.2165/00023210-200216100-00004 · Cited by 690
Metadata
- Authors
- Isojärvi, J. I. T., Rättyä, J., Myllylä, V. V., Knip, M., Koivunen, R., Pakarinen, A. J., Tekay, A., & Tapanainen, J. S.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1998-04
- Volume
- 43
- Issue
- 4
- Pages
- 446-451
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2157274804
- Cited by
- 342
- References
- 22
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.